Try our Advanced Search for more refined results

April 03, 2019

In re: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. June 24, 2021

    FlatWing Denied Atty Fees In Patent Fight With Pfizer Unit

    A federal magistrate judge has recommended against shifting nearly $690,000 in fees and expenses to Pfizer unit Anacor Pharmaceuticals from a company that challenged Anacor's patent for a toenail fungus treatment, citing an absence of evidence that Anacor pursued unreasonable infringement claims or patent defenses.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!